Clobetasol propionate is a highly potent topical glucocorticoid widely used in clinical practice. Its anti-inflammatory, anti-allergic, antiproliferative and antipruritic effects are far stronger than those of moderate and weak-potency steroids such as hydrocortisone and mometasone furoate. It is extensively applied for inflammatory and proliferative skin disorders including severe eczema, psoriasis, discoid lupus erythematosus, hypertrophic neurodermatitis, etc. Owing to its high potency, abuse or long-term large-area application can easily trigger corticosteroid adverse reactions. Adherence to standardized administration precautions is the core of safe treatment. This article systematically sorts out relevant points from the perspectives of applicable populations, dosage and administration, contraindications, prevention of adverse reactions, and medication under special scenarios.
I. Strictly Define Indications to Prevent Blind Medication
1.Administer only for indicated conditions; do not use as an all-purpose antipruritic ointment It is only indicated for non-infectious inflammatory skin diseases: plaque-type hypertrophic psoriasis, severe atopic dermatitis, chronic hypertrophic eczema, lichen planus, discoid lupus erythematosus, severe swelling and pruritus caused by insect bites, and so forth. It is strictly prohibited for monotherapy on infectious lesions, including fungal diseases (tinea manus, tinea pedis, tinea corporis, tinea cruris), bacterial diseases (impetigo, folliculitis), and viral diseases (herpes, verrucae). If lesions are complicated with infection, antifungal, antibacterial or antiviral agents must be administered concomitantly. Clobetasol propionate alone shall not be used to suppress inflammation and mask infection.
2.Differentiate application sites; exercise caution on delicate skin areas
The penetration rate of steroids depends on the thickness of the stratum corneum. Delicate skin areas with abundant blood vessels and high drug absorption, such as the face, eyelids, lips, axillae, groin, breasts, vulva and perianal region, are not recommended for clobetasol propionate as the first-line agent in principle. If short-term control of hypertrophic lesions is clinically necessary, only minimal doses shall be applied for a short course (no more than 1 week), and occlusion is forbidden.
Palms, soles and limbs with hypertrophic keratinized plaques feature low drug absorption, making them the most suitable sites for this preparation.
II. Standardized Dosage & Administration; Strict Control over Dose, Treatment Course and Occlusion
1.Apply a thin film of the ointment
Take a small amount of ointment, spread it thinly and evenly on the affected area, and rub gently until fully absorbed. Thick coating is prohibited. Excessive application yields no therapeutic improvement yet exponentially raises the risk of systemic absorption.
2.Restrict maximum treatment duration
Long-term topical use of super-high-potency steroids damages the skin barrier. Standard continuous treatment limits: for adults, continuous medication on a single lesion shall not exceed 2 weeks; the total course for widespread extensive lesions shall be no longer than 4 weeks. After symptom relief, taper the dose gradually before discontinuation; abrupt cessation is forbidden to avoid inflammatory rebound and aggravated rash recurrence.
3.Occlusive dressing therapy only under physician instruction
Occlusion drastically increases percutaneous absorption. It may only be used for a short period upon physician assessment for severely hypertrophic, hyperkeratotic plaque psoriasis and chronic lichenified dermatitis. Patients must not perform self-occlusion with plastic wrap or gauze at home, as this may readily induce systemic corticosteroid reactions and skin atrophy.
4.Strict limit on application area
The total application area for adults per use is recommended not to exceed 10% of the body surface area. For extensive widespread lesions, monotherapy with clobetasol propionate throughout the whole course is inadvisable; alternate segmented treatment with moderate or low-potency steroids is acceptable.
III. Precautions for Storage, Compatibility and Combined Medication
1.Storage: Keep tightly sealed in a cool and dry place, avoid direct sunlight, store out of children's reach to prevent accidental oral ingestion.
2.Combined anti-infective therapy: For concurrent fungal infection, apply antifungal agents and clobetasol propionate separately in the morning and evening; mixing them in one preparation is not allowed. For bacterial infection, control infection with antibacterial agents first prior to anti-inflammatory treatment.
3.Do not apply other high-potency steroids concomitantly topically to prevent excessive total steroid exposure.
4.Wash hands thoroughly immediately after application; avoid rubbing eyes, nasal and oral mucous membranes with contaminated hands. Use on mucosal sites (oral cavity, vagina, nasal cavity) is completely contraindicated at all times.
